Learn how Stanford Medicine Catalyst is helping TrNK launch a clinic-ready therapy for solid tumors, whose stubborn defenses often thwart effective treatment. If you have an innovation that could be a good fit for Catalyst, consider applying by March 16. At Stanford Medicine, Catalyst accelerates innovations with funding, incubation support, network connections and more to drive real-world, global impact. TrNK joined Catalyst in May 2024 as one such venture. When the laborato

Kidney Pod, a Stanford Medicine Catalyst supported project, is a novel organ transplantation device which maintains organs at an optimal temperature throughout the transplantation procedure.

A project supported by Stanford Medicine Catalyst is revolutionizing patient care through pharmacogenomics — personalized prescriptions...

Stanford Medicine Catalyst is excited to announce that our application window is now open.  We are seeking transformative innovations in...

The AVATAR project, launched by Stanford Medicine Catalyst in May 2024, is enhancing pediatric radiotherapy by improving comfort and reducing the need for anesthesia. The innovation has been deployed to 20 global sites in just one year.

Filling an unmet need for Parkinson’s disease The number of people living with Parkinson's disease (PD) globally has doubled in the past...